Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Lion Corp    4912   JP3965400009

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

LION : Notice Concerning the Determination of Items Relating to the Issuance of Subscription Rights (Stock Options)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/18/2012 | 03:22am CET

Lion Corporation ("Lion" or "the Company") today announced details of its decision to issue stock options (subscription rights) as part of a stock-linked compensation plan. The decision was made at a Board of Directors' meeting held on March 29, 2012 (see press release dated March 29, 2012), with certain details to be determined. Outstanding issues have now been decided and are provided as follows.

1. Total number of subscription rights to be issued:
96,418 rights

2. Number of executive officers to whom subscription rights shall be allotted and the number of subscription rights to be allotted:
Directors (excluding external directors):8; 96,418 rights

3. Total Payment due Upon Exercise of Subscription Rights:
Payment per subscription right:¥405(Payment per share:¥405)
Notes: 1. The aforementioned amounts were calculated using the Black-Scholes model on the subscription rights allocation date.
Notes: 2. Subscription rights are acquired after compensation claims by individuals eligible for subscription rights are offset by subscription right payment obligations.

4. Class and number of shares to be acquired upon exercise of subscription rights:
96,418 shares of Lion common stock
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LION CORP
02/16 LION : Investigators at Lion Corporation Target Porphyromonas (Decreased express..
02/07LION CORP : annual earnings release
2016 LION CORP : ex-dividend day for final dividend
2016 LION : Patent Issued for Panaxadiol-Containing Composition (USPTO 9510613)
2016 LION : Global Fatty Methyl Ester Sulfonates (FMES) Market – Lion Corporati..
2016 LION : Revises Performance and Dividend Forecasts
2016 LION CORP : ex-dividend day for interim dividend
2016 LION : Revises Performance Forecasts
2016 LION : Notice Concerning Issuance of Subscription Rights (Stock Options)
2016 LION : Notice Concerning the Change of a Representative Director
More news
Sector news : Household Products - NEC
02/11DJReckitt Agrees to Mead Deal -- WSJ
02/11DJWHAT'S NEWS : Business & Finance -- WSJ
02/10 FTSE gets mining boost, hits three-week high
02/10DJRECKITT BENCKISER : to Buy Mead Johnson for $16.6 Billion -- 4th Update
02/10DJReckitt Benckiser to Buy Mead Johnson for $16.6 Billion -- 3rd Update
More sector news : Household Products - NEC
Advertisement
Financials ( JPY)
Sales 2017 412 478 M
EBIT 2017 -
Net income 2017 17 760 M
Finance 2017 77 870 M
Yield 2017 0,78%
P/E ratio 2017 30,78
P/E ratio 2018 27,38
EV / Sales 2017 1,19x
EV / Sales 2018 1,12x
Capitalization 568 319 M
More Financials
Chart LION CORP
Duration : Period :
Lion Corp Technical Analysis Chart | 4912 | JP3965400009 | 4-Traders
Full-screen chart
Technical analysis trends LION CORP
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Average target price 1 883  JPY
Spread / Average Target -0,90%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Itsuo Hama President, CEO & Representative Director
Toshio Kakui Director, Head-Research & Development Division
Hideo Yamada Independent Director
Yuji Watari Senior Managing Representative Director
Kenjiro Kobayashi Secretary, Director & Executive Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LION CORP-0.84%5 035
RECKITT BENCKISER GROU..3.11%61 670
UNILEVER INDONESIA TBK..--.--%24 378
CLOROX CO11.41%17 150
CHURCH & DWIGHT CO., I..12.47%12 853
KOBAYASHI PHARMACEUTIC..3.79%3 780
More Results